Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
5,133,431
-
Shares change
-
+452,613
-
Total reported value, excl. options
-
$718,724,343
-
Value change
-
+$63,854,991
-
Put/Call ratio
-
38.3%
-
Number of buys
-
76
-
Number of sells
-
-56
-
Price
-
$140.01
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2018
178 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2018.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,133,431 shares
.
Largest 10 shareholders include MORGAN STANLEY (972,875 shares), WELLS FARGO & COMPANY/MN (734,078 shares), BANK OF AMERICA CORP /DE/ (700,661 shares), UBS Group AG (416,783 shares), CHURCHILL MANAGEMENT Corp (299,850 shares), Navellier & Associates Inc (170,130 shares), AMERIPRISE FINANCIAL INC (161,042 shares), ROYAL BANK OF CANADA (158,510 shares), RAYMOND JAMES & ASSOCIATES (144,020 shares), and LPL Financial LLC (132,601 shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.